Clinical trials recruiting for HIV/AIDS
24
Recruiting trials
12
US states with sites
8
Countries
50%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Phase 3 1Not applicable 21
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CAR-T cells | 1 |
| DTG/3TC | 1 |
| Lpv/r+3TC | 1 |
| TAF/FTC 25mg/200mg fixed-dose combination tablets | 1 |
| TDF/FTC 300mg/200mg fixed-dose combination tablets | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| New York | 3 |
| Florida | 2 |
| Mississippi | 2 |
| North Carolina | 2 |
| Alabama | 1 |
| Illinois | 1 |
| Louisiana | 1 |
| Massachusetts | 1 |
| Pennsylvania | 1 |
| Rhode Island | 1 |
| Texas | 1 |
Top cities
New York, New York 3Jackson, Mississippi 2Miami, Florida 2Boston, Massachusetts 1Chicago, Illinois 1Durham, North Carolina 1Hobson City, Alabama 1Houston, Texas 1La Jolla, California 1Los Angeles, California 1
Self-screener
Recruiting trials
- A Mobile Gaming App to Improve Adherence to PrEP
- ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
- An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi
- An Integrated Intervention Using a Pill Ingestible Sensor System
- An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
- Appalachian Partnership to Reduce Disparities (Aim 2)
- Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
- Dolutegravir Plus Lamivudine Simplified Therapy
- Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
- Enhancing the Organizational Social Context to Improve Viral Suppression and Retention in HIV Care
- INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
- Measuring Adverse Pregnancy and Newborn Congenital Outcomes
- MyPEEPS LITE Trial
- MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
- Observational Pharmaco-Epidemiology Research & Analysis
- Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study
- PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women
- Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
- Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- SCOPE Analytic Treatment Interruption Protocol
- Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
- Simplified Treatment of Anti-retrovirus in China (C-STAR)
- The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
- Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement
Related conditions
Trials recruiting for HIV/AIDS often also study these conditions. Each links to its own recruiting-trial list.
HIV 599Medication Adherence 14Substance Use Disorders 15Social Determinants of Health (SDOH) 4Rheumatic Diseases 9Pregnancy Related 28Opioid-use Disorder 11Nonalcoholic Steatohepatitis 6NASH 218Neurodegenerative Diseases 23
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HIV/AIDS trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.